Oncimmune Holdings (UK) Performance

ONC Stock   1.14  0.05  4.20%   
The company holds a Beta of -1.4, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Oncimmune Holdings are expected to decrease by larger amounts. On the other hand, during market turmoil, Oncimmune Holdings is expected to outperform it. At this point, Oncimmune Holdings plc has a negative expected return of -3.57%. Please make sure to check Oncimmune Holdings' standard deviation, maximum drawdown, kurtosis, as well as the relationship between the total risk alpha and potential upside , to decide if Oncimmune Holdings plc performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Oncimmune Holdings plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Begin Period Cash Flow3.2 M
Free Cash Flow-3.4 M
  

Oncimmune Holdings Relative Risk vs. Return Landscape

If you would invest  1,580  in Oncimmune Holdings plc on December 18, 2024 and sell it today you would lose (1,466) from holding Oncimmune Holdings plc or give up 92.78% of portfolio value over 90 days. Oncimmune Holdings plc is generating negative expected returns and assumes 10.6771% volatility on return distribution over the 90 days horizon. Simply put, 95% of stocks are less volatile than Oncimmune, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Oncimmune Holdings is expected to under-perform the market. In addition to that, the company is 12.5 times more volatile than its market benchmark. It trades about -0.33 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.02 per unit of volatility.

Oncimmune Holdings Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Oncimmune Holdings' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Oncimmune Holdings plc, and traders can use it to determine the average amount a Oncimmune Holdings' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.3343

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsONC

Estimated Market Risk

 10.68
  actual daily
95
95% of assets are less volatile

Expected Return

 -3.57
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.33
  actual daily
0
Most of other assets perform better
Based on monthly moving average Oncimmune Holdings is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oncimmune Holdings by adding Oncimmune Holdings to a well-diversified portfolio.

Oncimmune Holdings Fundamentals Growth

Oncimmune Stock prices reflect investors' perceptions of the future prospects and financial health of Oncimmune Holdings, and Oncimmune Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Oncimmune Stock performance.

About Oncimmune Holdings Performance

By analyzing Oncimmune Holdings' fundamental ratios, stakeholders can gain valuable insights into Oncimmune Holdings' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Oncimmune Holdings has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Oncimmune Holdings has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.

Things to note about Oncimmune Holdings plc performance evaluation

Checking the ongoing alerts about Oncimmune Holdings for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Oncimmune Holdings plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Oncimmune Holdings generated a negative expected return over the last 90 days
Oncimmune Holdings has high historical volatility and very poor performance
Oncimmune Holdings may become a speculative penny stock
Oncimmune Holdings has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 2.74 M. Net Loss for the year was (4.11 M) with profit before overhead, payroll, taxes, and interest of 1.23 M.
Oncimmune Holdings generates negative cash flow from operations
About 32.0% of the company outstanding shares are owned by corporate insiders
Evaluating Oncimmune Holdings' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Oncimmune Holdings' stock performance include:
  • Analyzing Oncimmune Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Oncimmune Holdings' stock is overvalued or undervalued compared to its peers.
  • Examining Oncimmune Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Oncimmune Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Oncimmune Holdings' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Oncimmune Holdings' stock. These opinions can provide insight into Oncimmune Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Oncimmune Holdings' stock performance is not an exact science, and many factors can impact Oncimmune Holdings' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Oncimmune Stock analysis

When running Oncimmune Holdings' price analysis, check to measure Oncimmune Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncimmune Holdings is operating at the current time. Most of Oncimmune Holdings' value examination focuses on studying past and present price action to predict the probability of Oncimmune Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncimmune Holdings' price. Additionally, you may evaluate how the addition of Oncimmune Holdings to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance